Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThe Lancet
DOIs
Publication statusPublished - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Pravastatin
  • Medicine
  • Hazard ratio
  • Myocardial infarction
  • Internal medicine
  • Stroke (engine)
  • Clinical endpoint
  • Placebo
  • Statin
  • Randomized controlled trial
  • Cardiology
  • Cholesterol
  • Confidence interval
  • Mechanical engineering
  • Alternative medicine
  • Pathology
  • Engineering

Cite this